OSR Health, Inc. (OSRHW) income statement

OSRHWOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as OSRH

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30

$0.01+0.00 (0.00%)

Close on Oct 19, 2026Market cap $325.06KP/E –Yield –

OSR Health, Inc. income statement

Millions of USD, except per-share data. Shares in millions.

Line item	Q2 2026 2026-06-30	Q1 2026 2026-03-31	Q4 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30	Q1 2025 2025-03-31	Q4 2024 2024-12-31	Q3 2024 2024-09-30	Q2 2024 2024-06-30	Q1 2024 2024-03-31	Q4 2023 2023-12-31	Q3 2023 2023-09-30	Q2 2023 2023-06-30	Q1 2023 2023-03-31	Q4 2022 2022-12-31	Q3 2022 2022-09-30	Q2 2022 2022-06-30	Q1 2022 2022-03-31
Revenue	0.32	0.48	0.38	0.63	1.14	0.76	0.92	0.82	0.88	0.91	–	–	–	–	–	–	–	–
Cost of Revenue	0.23	0.32	0.25	0.37	1.10	0.59	0.76	0.64	0.65	0.67	–	–	–	–	–	–	–	–
Gross Profit	0.09	0.16	0.13	0.26	0.03	0.17	0.16	0.18	0.23	0.24	–	–	–	–	–	–	–	–
Research & Development	0.09	0.11	0.18	–	0.05	0.09	0.01	0.05	0.05	0.05	–	–	–	–	–	–	–	–
Selling, General & Admin	3.12	3.83	6.52	4.07	5.26	3.09	1.77	3.75	3.44	3.54	0.86	0.41	0.28	0.28	0.01	0.02	0.00	–
Advertising Expenses	–	0.00	–	–	–	–	0.00	–	0.00	0.00	–	–	–	–	–	–	–	–
Operating Income	-3.03	-3.67	-6.39	-3.80	-5.23	-2.92	-1.61	-3.57	-3.21	-3.30	–	–	–	–	–	–	–	–
Interest Expense	0.01	0.03	0.41	0.04	0.04	0.02	0.03	0.01	0.00	0.00	–	–	–	–	–	–	–	–
Interest & Investment Income	0.00	0.02	0.02	0.02	0.02	0.00	0.01	0.00	0.00	0.01	0.93	0.62	0.81	0.42	–	–	–	–
Pretax Income	-1.44	-3.92	-7.78	-4.49	-5.23	-11	-1.79	-3.50	-3.25	-3.36	–	–	–	–	–	–	–	–
Income Tax Expense	-0.44	-0.45	-0.53	-1.29	–	–	-0.45	-0.14	-0.97	0.00	0.15	0.13	0.23	0.03	–	–	–	–
Income from Continuing Operations	–	–	–	–	–	–	–	-0.45	-0.48	-0.45	-0.86	-0.41	-0.28	-0.28	-0.01	-0.02	0.00	–
Net Income incl. Noncontrolling Interests	-1.00	-3.47	-7.25	-3.19	-5.23	-11	-1.34	-3.36	-2.28	-3.36	-0.09	0.08	0.30	0.11	-0.06	0.02	0.00	0.00
Minority Interest in Earnings	-0.16	-0.54	-2.42	-1.07	-5.56	–	–	0	–	–	–	–	–	–	–	–	–	–
Net Income	–	–	–	–	–	–	-2.02	-0.23	-0.10	-0.06	-0.09	0.08	0.30	0.11	-0.01	-0.02	0.00	0.00
Net Income to Common	-0.85	-2.93	-4.82	-2.13	0.33	-11	-1.34	-3.36	-2.28	-3.36	–	–	–	–	–	–	–	–
EPS (Basic)(per share)	-0.02	-0.09	–	-0.10	0.02	-1.04	–	-1.56	-0.41	-0.60	-0.01	0.01	0.03	0.02	-0.01	-0.01	0.00	–
EPS (Diluted)(per share)	-0.03	-0.08	–	–	–	-1.04	–	-0.06	-0.02	-0.01	-0.01	0.01	0.03	0.02	-0.01	-0.01	0.00	–
Shares Outstanding (Basic, Weighted)(shares)	35	31	26	22	19	11	2.16	4.04	4.95	5.62	7.41	9.06	9.06	5.23	1.50	1.50	1.50	–
Shares Outstanding (Diluted, Weighted)(shares)	33	34	21	39	19	11	2.16	4.04	4.95	5.62	7.41	9.06	9.06	5.23	1.50	1.50	1.50	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 35.3%
Operating margin: -933.7%
Net margin: –
Return on equity, FY2025: –

Financial strength

Current ratio: 0.18
Debt to equity: –
Debt to assets: 1.6%
Cash to current liabilities: 9.5%

Valuation

P/E ratio: –
Price to sales: 0.18
Price to book: –
Dividend yield: –